Bellevue Group’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-9,000
Closed -$660K 170
2022
Q4
$660K Buy
+9,000
New +$660K 0.01% 149
2022
Q3
Sell
-25,300
Closed -$1.76M 181
2022
Q2
$1.76M Buy
25,300
+16,800
+198% +$1.17M 0.02% 133
2022
Q1
$704K Buy
+8,500
New +$704K 0.01% 153